Psychedelic Mushrooms Market Poised For $3.3 Billion Surge By 2031
The psychedelic mushroom market is projected to more than double in size by 2031, growing from $1.5 billion in 2024 to an estimated $3.3 billion. A recent report by Persistence Market Research predicts a strong compound annual growth rate (CAGR) of 10.3% driven by increasing scientific research, evolving regulatory environments and growing interest in psilocybin as a potential mental health treatment. This robust growth builds on a historical CAGR of 8.12% from 2019 to 2023, signaling a promising future for the market.
The Therapeutic Shift: From Recreational Stigma To Mental Health Solution
Once viewed mainly as a recreational substance, psychedelic mushrooms, particularly those containing psilocybin, are gaining recognition for their potential to treat mental health conditions like depression, PTSD, anxiety and addiction. Psilocybin has shown promise in promoting neuroplasticity, which may aid brain regeneration and even be useful for conditions like Alzheimer’s and Huntington’s disease. With growing interest in wellness and alternative therapies, demand for psilocybin-based products, such as teas, powders and microdosing kits, is rising. As more people recognize its benefits, the market for psilocybin is set for significant expansion.
Read Also: Veterans Deserve Access To Life-Changing Psychedelics …